Showing results (11-20 of 92) with videos related to
Sort By:
Pageof 10
Oncotarget|January 11, 2015
DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistanceRoland M Huber, Jared M Lucas, Luis A Gomez-Sarosi, et al.Cancer Letters|February 28, 2006
Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivoQian Chen, Jeffery T Watson, Susan Ruth Marengo, et al.European Urology|June 27, 2016
Expression of STAT3 in Prostate Cancer MetastasesNicholas Don-Doncow, Felicia Marginean, Ilsa Coleman, et al.Cancer Letters|July 8, 2014
Spheroid culture of LuCaP 147 as an authentic preclinical model of prostate cancer subtype with SPOP mutation and hypermutator phenotypeMatthias Saar, Hongjuan Zhao, Rosalie Nolley, et al.International Journal of Cancer|December 21, 2004
Loss of stearoyl-CoA desaturase expression is a frequent event in prostate carcinomaStacy Moore, Beatrice Knudsen, Lawrence D True, et al.Neoplasia (New York, N.Y.)|September 13, 2013
AR variant ARv567es induces carcinogenesis in a novel transgenic mouse model of prostate cancerGang Liu, Cynthia Sprenger, Shihua Sun, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumorsJennifer D Wu, Kathy Haugk, Ilsa Coleman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
An antibody targeting the type I insulin-like growth factor receptor enhances the castration-induced response in androgen-dependent prostate cancerStephen R Plymate, Kathy Haugk, Ilsa Coleman, et al.Plos One|May 25, 2013
Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulationLina Gao, Jacob Schwartzman, Angela Gibbs, et al.Anticancer Research|July 3, 2017
Inhibition of ERG Activity in Patient-derived Prostate Cancer Xenografts by YK-4-279Brian Winters, Lisha Brown, Ilsa Coleman, et al.Pageof 10